Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
8.33
-0.76 (-8.36%)
Dec 27, 2024, 4:00 PM EST - Market closed
Avalo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 27, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 87 | 7 | 47 | 191 | 4,212 | 18,865 | |
| Market Cap Growth | 418.10% | -84.63% | -75.15% | -95.47% | -77.67% | 14214.17% | |
| Enterprise Value | 7 | -1 | 52 | 153 | 4,180 | 18,877 | |
| Last Close Price | 8.33 | 9.10 | 1209.61 | 4895.96 | 7603.14 | 15523.08 | |
| PS Ratio | 21.03 | 3.79 | 2.63 | 35.37 | 628.78 | 2794.73 | |
| PB Ratio | 3.83 | 1.00 | -4.35 | 8.27 | 171.49 | 898.54 | |
| P/TBV Ratio | 8.70 | - | - | 22.11 | 491.62 | 4534.72 | |
| EV/Sales Ratio | 8.46 | - | 2.87 | 28.36 | 624.03 | 2796.40 | |
| Debt / Equity Ratio | 0.07 | 0.26 | -1.98 | 1.53 | 0.06 | 0.06 | |
| Asset Turnover | 0.01 | 0.07 | 0.32 | 0.09 | 0.17 | 0.13 | |
| Inventory Turnover | - | - | 896.21 | 2444.83 | 2074.05 | 68.56 | |
| Quick Ratio | 1.37 | 1.64 | 0.68 | 2.99 | 1.53 | 0.39 | |
| Current Ratio | 1.42 | 1.82 | 0.74 | 3.11 | 1.71 | 1.46 | |
| Return on Equity (ROE) | -42.52% | - | -684.77% | -354.08% | -282.65% | -77.66% | |
| Return on Assets (ROA) | -30.64% | -53.91% | -32.95% | -82.82% | -74.02% | -22.32% | |
| Return on Capital (ROIC) | -95.33% | -146.88% | -54.11% | -121.58% | -122.42% | -55.00% | |
| Earnings Yield | -9.33% | -432.43% | -87.80% | -44.19% | -1.51% | -0.09% | |
| FCF Yield | -42.19% | -422.75% | -56.58% | -37.19% | -0.96% | -0.10% | |
| Buyback Yield / Dilution | -2315.84% | -608.45% | -8.32% | -41.86% | -28.53% | -64.39% | |
| Total Shareholder Return | -2315.84% | -608.45% | -8.32% | -41.86% | -28.53% | -64.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.